![](https://endpts.com/wp-content/uploads/2022/04/Mike-Cloonan-Sionna-tile.jpg)
Mike Cloonan, Sionna Therapeutics CEO
Sionna licenses clinical-stage cystic fibrosis assets from AbbVie shortly after large Series C
Sionna Therapeutics snagged the exclusive worldwide license to three of AbbVie’s cystic fibrosis drug candidates as the biotech aims to beef up its work in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.